| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
842 |
754 |
$27K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
258 |
253 |
$13K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
117 |
111 |
$12K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
167 |
156 |
$8K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
233 |
222 |
$7K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
506 |
464 |
$4K |
| 99215 |
Prolong outpt/office vis |
42 |
41 |
$2K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
296 |
271 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
85 |
84 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
57 |
53 |
$819.05 |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
13 |
13 |
$570.14 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
43 |
37 |
$394.23 |
| 99000 |
|
13 |
13 |
$129.60 |
| 81002 |
|
14 |
14 |
$35.04 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
13 |
13 |
$19.27 |